Rheumatoid Arthritis News

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis through 52 weeks, according to phase 3 trial results published in Annals of the Rheumatic Diseases.

A prospective chart review suggests a novel asthma phenotype associated with rheumatoid arthritis, with possible common causality, according to results published in The Journal of Allergy and Clinical Immunology: In Practice.

Patients with rheumatoid arthritis who demonstrate consistent long-term elevation of inflammatory markers have an increased risk for interstitial lung disease, according to data published in Arthritis Research & Therapy.

WASHINGTON — High rates of premature mortality from rheumatoid arthritis among Native American populations have seen no change in the past 20 years, while other races have demonstrated improving trends, according to data.

WASHINGTON — Rising rates of ACR20 response in the placebo arms of rheumatoid arthritis trials may be related to increasingly globalized recruitment patterns, according to data presented at ACR Convergence 2024.

WASHINGTON — Patients who use medication or surgery to achieve at least 5% weight loss demonstrate greater improvements in patient-reported outcomes across various rheumatic diseases, according to data presented at ACR Convergence 2024.

WASHINGTON — In this video, Ambreesh Chawla, MD, summarizes salient and practice-changing presentations in rheumatoid arthritis from ACR Convergence 2024.

WASHINGTON — Delaying methotrexate initiation for 1 month after pneumococcal vaccination improves humoral response in patients with rheumatoid arthritis, according to data presented at ACR Convergence 2024.

WASHINGTON — An early, 1-year course of methotrexate may prevent anti-citrullinated protein autoantibody-negative rheumatoid arthritis in high-risk patients with clinically suspect arthralgia, noted a presenter at ACR Convergence 2024.